Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Amphastar Pharmaceuticals, Inc. (AMPH : NSDQ)
 
 • Company Description   
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Number of Employees: 1,976

 
 • Price / Volume Information   
Yesterday's Closing Price: $18.41 Daily Weekly Monthly
20 Day Moving Average: 737,983 shares
Shares Outstanding: 44.09 (millions)
Market Capitalization: $811.75 (millions)
Beta: 0.97
52 Week High: $31.26
52 Week Low: $16.65
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.38% -16.66%
12 Week -30.50% -35.75%
Year To Date -31.25% -37.65%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11570 SIXTH STREET
-
RANCHO CUCAMONGA,CA 91730
USA		 ph: 909-980-9484
fax: 909-980-8296		 jasons@amphastar.com http://www.amphastar.com
 
 • General Corporate Information   
Officers
Jack Yongfeng Zhang - Chief Executive Officer and President
Mary Z. Luo - Chairman and Chief Operating Officer
William J. Peters - Chief Financial Officer
Jacob Liawatidewi - Executive Vice President
Gayle M. Deflin - Director

Peer Information
Amphastar Pharmaceuticals, Inc. (BGMR)
Amphastar Pharmaceuticals, Inc. (MGX)
Amphastar Pharmaceuticals, Inc. (IPAH)
Amphastar Pharmaceuticals, Inc. (BRL)
Amphastar Pharmaceuticals, Inc. (BHC)
Amphastar Pharmaceuticals, Inc. (AKRXQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 03209R103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 44.09
Most Recent Split Date: (:1)
Beta: 0.97
Market Capitalization: $811.75 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.69 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.92 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 2.11% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.29
Trailing 12 Months: 7.51
PEG Ratio: 2.98
Price Ratios
Price/Book: 1.05
Price/Cash Flow: 4.33
Price / Sales: 1.13
EPS Growth
vs. Year Ago Period: -57.38%
vs. Previous Quarter: -57.38%
Sales Growth
vs. Year Ago Period: 0.38%
vs. Previous Quarter: -6.52%
ROE
03/31/26 - 15.12
12/31/25 - 17.58
09/30/25 - 19.70
ROA
03/31/26 - 7.14
12/31/25 - 8.27
09/30/25 - 9.17
Current Ratio
03/31/26 - 3.85
12/31/25 - 4.02
09/30/25 - 3.12
Quick Ratio
03/31/26 - 2.82
12/31/25 - 2.90
09/30/25 - 2.21
Operating Margin
03/31/26 - 16.24
12/31/25 - 18.77
09/30/25 - 20.55
Net Margin
03/31/26 - 11.00
12/31/25 - 13.63
09/30/25 - 15.43
Pre-Tax Margin
03/31/26 - 14.27
12/31/25 - 17.17
09/30/25 - 18.76
Book Value
03/31/26 - 17.54
12/31/25 - 17.17
09/30/25 - 16.71
Inventory Turnover
03/31/26 - 2.09
12/31/25 - 1.97
09/30/25 - 2.04
Debt-to-Equity
03/31/26 - 0.79
12/31/25 - 0.77
09/30/25 - 0.78
Debt-to-Capital
03/31/26 - 44.09
12/31/25 - 43.56
09/30/25 - 43.93
 

Powered by Zacks Investment Research ©